Literature DB >> 32982444

Acceptance of Human Papillomavirus Vaccination and Associated Factors Among Parents of Daughters in Gondar Town, Northwest Ethiopia.

Tsigereda Alene1, Asmamaw Atnafu2, Zeleke Abebaw Mekonnen3,4, Amare Minyihun2.   

Abstract

BACKGROUND: Cervical cancer is one of the profound threats to women's lives and the fourth most common cancer among women. Ethiopia launched the human papilloma vaccination for the first time, with the support of the Global Alliance for Vaccine and Immunization (GAVI) in 2018. Therefore, the aim of this study was to assess the acceptability of the human papillomavirus vaccine and associated factors among parents of daughters in Gondar town, Northwest Ethiopia.
METHODS: A community-based cross-sectional study with a total sample of 946 study participants was conducted in Gondar town from April to May 2019. The study participants were selected using a multistage sampling technique from parents having a daughter of 9-17 years age. Data were collected using an interviewer-administered questionnaire. The data were entered into EpiData version 4.2 and exported to STATA version 14 for analysis. Variables having a p-value of <0.2 and <0.05 in the bivariable and multivariable logistic regression were considered as a statistically significant factor for the acceptance of HPV vaccination.
RESULTS: A total of 899 study participants with a response rate of 95% were included in the study. Among participants in this study, 81.3% with 95% CI (78.6, 83.7) accepted to vaccinate their daughters for HPV vaccination. The acceptance to vaccinate daughters for HPV vaccination was affected by being from the richest household [AOR= 3.44, 95% CI = (1.97, 6.01)], good knowledge about cervical cancer [AOR=5.49, 95% CI= (2.62, 11.52)], and positive attitude towards HPV vaccination [AOR=21.53, 95% CI= (11.60, 39.96)].
CONCLUSION: The study revealed that the acceptance to human papillomavirus vaccination is high and was significantly associated with the level of knowledge about cervical cancer, the attitude towards HPV vaccination, and the wealth status of the households. Therefore, community education on cervical cancer and its prevention is crucial to increase awareness and acceptance as well.
© 2020 Alene et al.

Entities:  

Keywords:  Gondar town; HPV; acceptance; cervical cancer; daughters

Year:  2020        PMID: 32982444      PMCID: PMC7502398          DOI: 10.2147/CMAR.S275038

Source DB:  PubMed          Journal:  Cancer Manag Res        ISSN: 1179-1322            Impact factor:   3.989


Introduction

Globally, cervical cancer is one of the gravest threats to women’s lives and the fourth most common cancer among women. It is estimated that over a million women currently have cervical cancer and up to 70% of the cases are caused by Human Papilloma Virus (HPV) type 16 and 18.1,2 Cervical cancer ranks second in incidence and mortality behind breast cancer in developing countries.2 The incidence and mortality in sub-Saharan Africa are among the highest in the world and account for over 70% of the global cervical cancer burden with 70,000 new cases annually.3 In Ethiopia, the current estimates indicate that every year 6294 women are diagnosed with cervical cancer and more than three-fourth of them dies from the disease.4 Most developed countries have well-organized strategies on organized screening, early detection, and successful treatment of precancerous cervical lesions. HPV vaccination provides an opportunity to low-resource settings to reduce the burden of cervical cancer, thus benefits of the vaccine are restricted to the minority of women who have not been infected yet.5–7 Ethiopia launched the HPV vaccine for the first time with the support of the Global Alliance for Vaccine and Immunization (GAVI) in 2018. The vaccine is currently being delivered primarily through a school-based approach to reach all eligible girls.8 In Ethiopia, misconceptions about the cause and prevention of cervical cancer are common due to a lack of awareness and health-seeking behavior. Therefore, before the nationwide scale-up of cervical cancer prevention programs, assessment of barriers to acceptance and use of the service through appropriate community-level studies are essential.7,9,10 Vaccine hesitancy is complicated and context-specific. Thus hesitancy is caused by individual, group, and discourse influences, yet as any vaccine-specific problems. Every country must take steps to understand the extent and nature of hesitancy at an area level, on an unbroken basis. Consequently, every country ought to develop a strategy to extend acceptance and demand for vaccination, that should embrace current community engagement and trust-building, active hesitancy hindrance, regular national assessments of considerations, and crisis response designing.11,12 Though vaccination is an effective way to reduce cervical cancer, people’s acceptance of vaccination remains a big challenge in developing countries.13 Empirical evidence with related to the willingness of the public to take the vaccine, associated factors, and its importance is not well assessed in many low and middle-income countries (LMICs) which is worse in Ethiopia. Thus, this study aimed to assess the acceptability of the human papillomavirus vaccine and associated factors among parents of daughters in Gondar town, northwest Ethiopia.

Methods

Study Area and Period

A community-based cross-sectional study was conducted in Gondar town from April to May 2019. Gondar town is 727 km away from Addis Ababa (the capital city of Ethiopia) and it is the capital city of the central Gondar Zone of the Amhara Region. It has six sub-cities with 25 urban and eleven rural kebeles. According to the Gondar town plan commission and Gondar health sector information office total population size was 390,644, two hospitals, one referral and one private hospital, eight health centers, and fourteen health posts.

Population

The source population was all parents who had daughters aged 9–17 years old living in Gondar town whereas the study population was all parents who had daughters age between 9–17 years old living in the selected kebeles for this particular study.

Sample Size Determination

The sample size was calculated by using both single and double population proportion formula. The sample size for the first objective was calculated using a single population proportion formula assuming 95% confidence interval (CI), 5% marginal error (d), and 50% expected acceptance, which yielded the sample size of 384. The sample size for the second objective was determined by using a double population proportion formula using Epi-Info TM 7 software using the following assumptions: 95% CI, power of 80%, Exposed unexposed ratio= 1, and Crude Odds Ratio (COR) of two significantly associated variables ie those parents who always used condoms (OR=1.77) and who perceived vaccination as acceptable (OR=7.91) from a cross-sectional study conducted at North Vietnam,14 which yields a sample size of 430. Accordingly, the largest sample was obtained from the second objective, and adding a 10% non-response rate and multiplied by a design effect of 2, the final sample size for this particular study was 946.

Sampling Procedure

The study participants were selected using the two-stage sampling technique. At the first stage of sampling, kebeles were stratified by urban and rural with which 5 urban and 3 rural kebeles were selected using a simple random sampling technique. In the second stage, 946 households were selected using a systematic sampling technique. The sample size for each kebele was allocated proportionally to their size.

Data Collection Procedures

An interviewer-administered questionnaire was used to collect the data. The questionnaire consists of questions on socio-demographic, economic, knowledge, attitude, and information related factors on the acceptability of the vaccination adapted from different literature. The questionnaire was initially prepared in English and translated into Amharic (national language) and again back to English to check for any inconsistencies. The pilot-testing was done out of the study area before the actual data collection by taking a sample of 5%. The reliability test for the data collection tool was checked and revealed the Cronbach alpha value of 0.82, 0.78, and 0.92 for knowledge, attitude, and wealth index respectively.

Measurements

Knowledge of the Participants

Was assessed among the participants about the cervical cancer cause, HPV prevention, and HPV vaccine. It was measured using 16 item knowledge questions and categorized as “Poor knowledge” (0–4 out of 16 items), “Moderate Knowledge” (5–12 out of 16 items), and “good Knowledge” (13 −16 out of 16 items).

Attitude

Was assessed among the participants about cervical cancer prevention, HPV vaccine safety, and effectiveness. It was measured using 12 item questions and categorized as negative (0–4 out of 12 items), neutral (5–8 out of 12 items), and positive (9–12 out of 12 items) attitudes.

Acceptability

Was analyzed for all respondents using a question “Are you willing to vaccinate your daughter for HPV vaccination which can protect against HPV infection? (options: Yes, No).

Wealth Index

It was calculated using 30 data items on a household’s ownership of selected assets, types of water access, and sanitation facilities and computed by Principal Component Analysis (PCA) and divided into three equal parts (three tiles) as poor, medium, and rich wealth index.

Data Processing and Analysis

The data were entered into EpiData version 4.2 and exported to STATA version 14 for cleaning, coding, and analysis. It was described using frequencies, percentages, and mean and SD to show the distribution of the outcome variable and associated factors with the outcome of interest. Bivariable and multivariable logistic regression analysis were used to see the association between acceptance to the HPV vaccination and the explanatory variables. Crude Odds Ratio (COR) and Adjusted Odds Ratio (AOR) with their 95% CIs were used to report the regression analysis outputs.

Results

Socio-Demographic Characteristics of the Respondents

A total of 899 study participants with a response rate of 95% were included in this study. The mean (SD) age of the respondents were 39 (±0.30) years and the majority 726 (80.7%) were female by sex, 632 (70.3%) were urban by residence, 596 (66.3%) were married by marital status, 430 (47.83%) were unable to read and write by education status, 373 (41.4%) were housewife by occupation and 749 (83.3%) were orthodox christen by religion. The majority of the respondents 239 (26.5%) had three children. Table 1
Table 1

Socio-Demographic Characteristics of Parents of Daughters in Gondar Town, Northwest Ethiopia, 2019 (N=899)

VariablesNumber (%)
Age in years21–29 years103(11.5)
30–39 years395(43.9)
≥40 years401(44.6)
SexMale173(19.2)
Female726(80.2)
ResidenceUrban632 (70.3)
Rural267(29.7)
Marital statusSingle57(6.3)
Married596(66.3)
Divorced112(12.46)
Widowed71(7.9)
Separate63(7.01)
ReligionOrthodox749 (83.3)
Muslim99(11)
Protestant25(2.78)
Other26(2.89)
Educational statusUnable to read and write430 (47.83)
Primary and secondary education226(25.14)
Diploma and above243 (27.03)
OccupationCivil servant156 (17.3)
Self-employers115 (12.9)
Merchant137(15.2)
Farmer62(6.9)
House wife373(41.4)
Other56(6.2)
Number of childrenLess than or equal to five789 (87.76)
Greater than five110 (12.24)
Number of daughtersOne604(67.2)
More than one295(32.8)
Wealth statusPoor293(32.6)
Medium305(34.0)
Rich301(33.4)
Socio-Demographic Characteristics of Parents of Daughters in Gondar Town, Northwest Ethiopia, 2019 (N=899)

Knowledge, Attitude and Acceptability of HPV Vaccination for Their Daughters

Among participants in this study, 731 (81.3%) with 95% CI (78.6, 83.7) were willing to vaccinate their daughters for the HPV vaccine. The majority of participants 496 (55.2%) had information about HPV infection, and only 142 (28.6%) of the participants were informed by health workers. Additionally, 374 (41.6%) of the participants have poor knowledge about cervical cancer and its risk factors and the majority of the participants 538 (59.9%) had positive attitudes towards the HPV vaccination. Table 2
Table 2

Knowledge, Attitude and Acceptability of HPV Vaccination for Their Daughters Among Parents of Daughters in Gondar Town, Northwest Ethiopia, 2019 (n=899)

VariablesDescriptionNumber (%)
Information about HPV infectionYes496(55.2)
No403(44.8)
Source of Information (n=496)Television/Radio250(50.5)
Health workers142(28.6)
Social media20(4.0)
Their friend74(14.9)
Others10(2.0)
Community perceived trusted source of information(n=899)Health extension worker277(30.8)
Website171(19.0)
Televission272(30.3)
Relative/friends/colleagues127 (14.1)
News paper15 (1.7)
Radio37(4.1)
Knowledge about cervical cancer and its risk factorsPoor374(41.6)
Moderate335(37.3)
Good190(21.1)
Attitude towards HPV vaccinationNegative83(9.2)
Neutral278(30.9)
Positive538(59.9)
Acceptability of the HPV vaccinationYes731(81.3)
No168(18.7)
Knowledge, Attitude and Acceptability of HPV Vaccination for Their Daughters Among Parents of Daughters in Gondar Town, Northwest Ethiopia, 2019 (n=899)

Factors Associated with Acceptance of HPV Vaccination for Their Daughters

In the multivariate logistic regression analysis wealth status, knowledge about cervical cancer, and attitude towards HPV vaccination were significantly associated with acceptance of HPV vaccination at a P-value of <0.05. Table 3
Table 3

Bivariable and Multivariable Analysis of Factors Associated with the Acceptability of HPV Vaccination Among Parents of Daughters in Gondar Town, Northwest Ethiopia, 2019 (n=899)

VariablesCategoryAcceptability of the HPV VaccinationCOR (95% CI)AOR (95% CI)
Yes (%)No (%)
Age21–29 years82(79.61)21(20.39)1:001:00
30–39 years334(84.56)61(15.44)1.40(0.80, 2.43)1.38(0.71, 2.69)
≥ 40years315(78.55)86(21.45)0.93(0.54, 1.60)0.84(0.42, 1.68)
ResidenceUrban516(80.50)125(19.50)1.21(0.82, 1.77)1.34(0.76, 2.39)
Rural215(83.33)43(16.67)1.001.00
Marital StatusSingle50(87.72)7(12.28)1.001:00
Married482(80.87)114(19.13)0.59(0.26, 1.33)0.64(0.24, 1.73)
Divorced94(83.93)18(16.07)0.73(0.28, 1.86)0.87(0.28, 2.74)
Widowed53(74.65)18(25.35)0.41(0.15, 1.07)0.43(0.13, 1.44)
Separate52(82.54)11(17.46)0.66(0.23, 1.84)0.64(0.19, 2.21)
Educational StatusUnable to read and write353(82.09)77(17.91)1.001:00
Primary and secondary182(80.53)44(19.47)0.90(0.59, 1.36)0.66(0.37, 1.15)
Diploma and above196(80.66)47(19.34)0.90(0.60, 1.36)0.37(0.20, 0.70)
Number of daughtersOne489(80.96)115(19.04)1.001:00
More than one242(82.03)53(17.97)1.07(0.74, 1.53)0.90(0.57, 1.42)
Wealth statusPoor203(69.28)90(30.72)1.001:00
Medium254(83.28)51(16.72)2.20(1.49, 3.26)*2.04(1.27, 3.27)*
Rich274(91.03)27(8.97)4.49(2.82, 7.17)*3.44(1.97, 6.01)*
InformationYes419(84.48)77(15.52)1.001.00
No312(77.42)91(22.58)0.63(0.44, 0.88)*1.10(0.65, 1.88)
Knowledge about cervical cancerPoor259(69.25)115(30.75)1.001.00
Moderate294(87.76)41(12.24)3.18(2.14, 4.71)*2.98(1.78, 4.97)*
Good178(93.68)12(6.32)6.58(3.52, 12.29)*5.49(2.62, 11.52)*
Attitude towards HPV vaccinationNegative34(40.96)49(59.04)1.001.00
Neutral193(69.42)85(30.58)3.27(1.97, 5.42)*4.03(2.27, 7.16)*
Positive504(93.68)34(6.32)21.36(12.22, 37.34)*21.53(11.60, 39.96)*

Notes: 1, reference category; *Signficant at p<0.05 level.

Abbreviations: COR, crude odds ratio; AOR, adjusted odds ratio; CI, confidence interval.

Bivariable and Multivariable Analysis of Factors Associated with the Acceptability of HPV Vaccination Among Parents of Daughters in Gondar Town, Northwest Ethiopia, 2019 (n=899) Notes: 1, reference category; *Signficant at p<0.05 level. Abbreviations: COR, crude odds ratio; AOR, adjusted odds ratio; CI, confidence interval. The study showed that parents from the richest households were 3.44 times more likely to accept HPV vaccination for their daughters as compared with their counterpart’s poorest household [AOR= 3.44, 95% CI = (1.97, 6.01)]. Similarly, parents from the middle wealth status were 2.04 times more likely to accept HPV vaccination for their daughters as compared with those parents from the poorest households after adjusting for other factors [AOR= 2.04, 95% CI = (1.27, 3.27)]. Pertaining parent’s knowledge about cervical cancer, parents who had good knowledge about cervical cancer and its risk factors were 5.49 times more likely to accept the vaccination than those with poor knowledge [AOR=5.49, 95% CI= (2.62, 11.52)]. Similarly, parents who had moderate knowledge about cervical cancer and its risk factors were 2.98 times more likely to accept HPV vaccination than those with poor knowledge [AOR=2.98, 95% CI= (1.78, 4.97)]. Holding other factors constant, parents who had a positive attitude about the HPV vaccination were 21.53 times more likely to accept HPV vaccination for their daughters than those who had negative attitudes [AOR=21.53, 95% CI= (11.60, 39.96)]. Besides, Parents who had a neutral attitude about the HPV vaccination were 4.03 times more likely to accept the vaccination for their daughters than those who had negative attitudes [AOR=4.03, 95% CI= (2.27, 7.16)].

Discussion

The study was conducted to assess the acceptability of human papillomavirus vaccination and associated factors among parents of daughters in Gondar town. The study showed that the majority of the respondents 731 (81.3%) accepted HPV vaccinations for their daughters and to their close families which is consistent with the previous studies in Ethiopia (79.6%),15 Nigeria (81.8%),16 and South Africa (80%).17 However, several studies conducted in different counties like Tanzania (93.0%),18 Nigeria (88.9%),19 Malaysia (87.1%),20 and Honduras (91.0%)21 have shown higher acceptance level than our finding. The discrepancy could be due to the introduction of a new vaccine program to our study participants which may affect their level of acceptance and information. Moreover, some of the above studies were conducted after the provision of the vaccine and summary of information to participants which can lead to an increased level of acceptance compared to participants without such kind of information and vaccine. On the other hand, previous studies conducted in Ethiopia (69.3%),15 United Arab Emirate (76.6%),17 and Nigeria (67.4%)22 have shown a lower level of acceptance to vaccination. This may be due to the study participant’s differences in socio-demographic characteristics and the level of information. The previous studies might have less information about the benefits of vaccines and the disease problem which might also due to the study time discrepancy. This study also noted that knowledge on cervical cancer was significantly associated with acceptability to the human papillomavirus vaccination. This study finding is consistent with previous studies in Malaysia,20,23 Honduras,21 UAE,7 Europe,24 and Kenya.25 This might also be justified that those who have a better knowledge of cervical cancer risk factors; disease severity and prevention methods will have more attention to know the vaccination and good attitude for the vaccination. Additionally, other findings conducted in Nigeria,22,26 Canada27 and United Arab Emirates7 revealed that the main reason for unwillingness was insufficient knowledge about the HPV vaccinations and fear of the side effect where the common reasons for the refusal were the side effects of the vaccination and lack of knowledge. This finding also revealed that respondents who had a positive attitude about the HPV vaccination was significant associated with the acceptability of the HPV vaccine. This finding is similar to most other concepts of different findings.3–5 This might be due to the fact that the parent acceptability of the HPV vaccine is largely driven by their attitudes and beliefs regarding the vaccine’s effectiveness, safety, and ease of access. Additionally, the general beliefs about the HPV vaccine’s propensity to cause harm or deliver benefits can determine the parent’s routine delay or facilitate their decisions to vaccinate for the vaccine. The present study indicated that the wealth status of parents had a statistically significant association with the acceptance of the HPV vaccination. This finding is consistent with studies done in Hong Kong28 and Vietnam.29,30 As an individual became economically wealthy; they may have additional money to be allocated for the promotion of their health in addition to basic needs. Additionally, those parents who had better wealth might have a probability to get an opportunity of mass media like TV, radio, and other sources of information for the HPV vaccinations.

Limitation

Even though this study lies relatively on a large sample size with a high response rate, due to the cross-sectional nature of the study establishment of a causal relationship could not be possible.

Conclusion

The study has shown that the acceptance to human papillomavirus vaccination is found to be high and willingness to accept was significantly associated with the level of knowledge of cervical cancer, the attitude towards the vaccination, and the wealth status of the households. Therefore, community education on cervical cancer and its prevention to increase awareness are necessary. Moreover, efforts should be made to enhance the awareness about HPV vaccination through mass media and other health education outlets towards HPV vaccination.
  22 in total

1.  Maternal support for human papillomavirus vaccination in Honduras.

Authors:  Rebecca B Perkins; Sarah M Langrish; Deborah J Cotton; Carol J Simon
Journal:  J Womens Health (Larchmt)       Date:  2010-11-22       Impact factor: 2.681

2.  National HPV immunisation programme: knowledge and acceptance of mothers attending an obstetrics clinic at a teaching hospital, Kuala Lumpur.

Authors:  Sharifa Wan Puteh Ezat; Rozita Hod; Jamsiah Mustafa; Ahmad Zailani Hatta Mohd Dali; Aqmar Suraya Sulaiman; Azlin Azman
Journal:  Asian Pac J Cancer Prev       Date:  2013

3.  Mothers' preferences and willingness to pay for HPV vaccines in Vinh Long Province, Vietnam.

Authors:  Christine Poulos; Jui-Chen Yang; Carol Levin; Hoang Van Minh; Kim Bao Giang; Diep Nguyen
Journal:  Soc Sci Med       Date:  2011-06-12       Impact factor: 4.634

4.  Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.

Authors:  Rémi Marty; Stéphane Roze; Xavier Bresse; Nathalie Largeron; Jayne Smith-Palmer
Journal:  BMC Cancer       Date:  2013-01-08       Impact factor: 4.430

5.  Knowledge of and attitude toward human papillomavirus infection and vaccines among female nurses at a tertiary hospital in Nigeria.

Authors:  Christian Chigozie Makwe; Rose Ihuoma Anorlu
Journal:  Int J Womens Health       Date:  2011-09-13

6.  Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania.

Authors:  Melissa S Cunningham; Emily Skrastins; Ryan Fitzpatrick; Priya Jindal; Olola Oneko; Karen Yeates; Christopher M Booth; Jennifer Carpenter; Kristan J Aronson
Journal:  BMJ Open       Date:  2015-03-10       Impact factor: 2.692

Review 7.  Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review.

Authors:  Stacey Perlman; Richard G Wamai; Paul A Bain; Thomas Welty; Edith Welty; Javier Gordon Ogembo
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

8.  Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-07-26       Impact factor: 17.586

9.  Knowledge and Acceptability of Human Papillomavirus Vaccination among Women Attending the Gynaecological Outpatient Clinics of a University Teaching Hospital in Lagos, Nigeria.

Authors:  Kehinde S Okunade; Oyebola Sunmonu; Gbemisola E Osanyin; Ayodeji A Oluwole
Journal:  J Trop Med       Date:  2017-12-19

10.  Attitudes of undergraduate university women towards HPV vaccination: a cross-sectional study in Ottawa, Canada.

Authors:  Rachel Fernandes; Beth K Potter; Julian Little
Journal:  BMC Womens Health       Date:  2018-08-02       Impact factor: 2.809

View more
  7 in total

1.  Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.

Authors:  Gedefaye Nibret Mihretie; Tewachew Muche Liyeh; Alemu Degu Ayele; Habtamu Gebrehana Belay; Tigist Seid Yimer; Agernesh Dereje Miskr
Journal:  Reprod Health       Date:  2022-06-10       Impact factor: 3.355

2.  Health Care System View of Human Papilloma Virus (HPV) Vaccine Acceptability by Emirati Men.

Authors:  Suzan Al Shdefat; Shamsa Al Awar; Nawal Osman; Howaida Khair; Gehan Sallam; Hassan Elbiss
Journal:  Comput Math Methods Med       Date:  2022-01-28       Impact factor: 2.238

3.  COVID-19 vaccine hesitancy among health professionals in a tertiary care center at the University of Gondar Specialized Hospital, Ethiopia: A cross-sectional study.

Authors:  Chilot Abiyu Demeke; Zemene Demelash Kifle; Berhanemeskel Weldegerima Atsbeha; Dawit Wondmsigegn; Dawit Kumilachew Yimenu; Alem Endashaw Woldeyohanins; Asmamaw Emagn Kasahun
Journal:  SAGE Open Med       Date:  2022-02-15

4.  Cervical cancer screening uptake and determinant factors among women in Ambo town, Western Oromia, Ethiopia: Community-based cross-sectional study.

Authors:  Shewaye F Natae; Digafe T Nigatu; Mulu K Negawo; Wakeshe W Mengesha
Journal:  Cancer Med       Date:  2021-10-27       Impact factor: 4.452

5.  Knowledge and Attitude Towards Human Papillomavirus Vaccine and Associated Factors Among Mothers Who Have Eligible Daughters in Debre Markos Town, Northwest Ethiopia.

Authors:  Melkam Tesfaye Sinshaw; Semarya Berhe; Siraye Genzeb Ayele
Journal:  Infect Drug Resist       Date:  2022-03-03       Impact factor: 4.003

6.  Willingness of Ethiopian Population to Receive COVID-19 Vaccine.

Authors:  Yitayeh Belsti; Yibeltal Yismaw Gela; Yonas Akalu; Baye Dagnew; Mihret Getnet; Mohammed Abdu Seid; Mengistie Diress; Yigizie Yeshaw; Sofonias Addis Fekadu
Journal:  J Multidiscip Healthc       Date:  2021-05-28

7.  Parents willingness to vaccinate their daughter against human papilloma virus and its associated factors in Bench-Sheko zone, southwest Ethiopia.

Authors:  Alemnew Destaw; Tewodros Yosef; Biruk Bogale
Journal:  Heliyon       Date:  2021-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.